Anti-Tau Alzheimer’s Disease 抗体 [GT-38] - Conformation-Specific
Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific
- BOND RX™ Validated
- 詳細を見る
Be the first to review this product! Submit a review
|
(10 Publications)
Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (ab246808) is a mouse monoclonal antibody detecting Tau Alzheimer’s Disease in IHC-P, IHC-Fr, ELISA. Suitable for Human.
別名を表示する
MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau
- IHC-Fr
Lab
Immunohistochemistry (Frozen sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
IHC image of Tau Alzheimer's Disease staining in a section of frozen human Alzheimer brain performed on a Leica BONDTM system using the standard protocol F. The section was incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- IHC-P
Collaborator
Immunohistochemistry paraffin embedded sections - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
GT-38 detects Alzheimer's disease (AD) tau pathology. Immunofluorescence staining with GT-38 (green) at 2 μg/mL followed by anti mouse-488 conjugated secondary detection antibody in 6 μm thick sections of paraffin embedded human AD hippocampus fixed in ethanol. Blue stain is DAPI positive nuclei.
This data and image were courteously provided by Dr. Garrett Gibbons, University of Pennsylvania
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
IHC image of Tau Alzheimer's Disease staining in a section of formalin-fixed paraffin-embedded human Alzheimer brain performed on a Leica BONDTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
IHC image of Tau Alzheimer's Disease staining in a section of formalin-fixed paraffin-embedded human normal brain performed on a Leica BONDTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- ELISA
Supplier Data
ELISA - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
GT-38 ELISA selectively detects AD-tau compared to tau monomer. GT-38 immobilized antibody selectively captures pathological tau derived from human AD brain tissue compared to recombinant tau monomer. GT-38 captured AD-tau antigens are detected with total tau rabbit polyclonal antibodies followed by HRP-conjugated anti-rabbit secondary and colorimetric readout. Total tau ELISA serves as a loading control demonstrating equivalent loading of total tau protein from both AD-tau and tau monomer.
Purified GT-38 mouse IgG1 antibody was coated on a 384 well plate at 450 ng/well (30 uL of 15 ng/uL) in 0.1 M NaHCO3 pH 9.6 at 4°C overnight. Plates were washed with PBST (phosphate buffered saline pH 7.2 with 0.05% Tween20) five times. GT-38 capture antibody was blocked with a commercial blocking solution 4°C overnight. Antigens consisted of either human brain derived insoluble tau enriched extract (AD-tau) or purified recombinant tau monomer. AD-tau was sonicated with a probe sonicator and antigens diluted in 0.2% BSA in PBS and applied to immobilized GT-38 and allowed to incubate 4°C overnight. Plates were washed with PBST five times. Rabbit polyclonal total tau detection antibody was diluted to 3.7 μg/mL in Buffer C (20 mM sodium phosphate pH 7.0, 2 mM EDTA, 400 mM sodium chloride, 1% BSA, 0.005% thimerosal), 30 μL was added to each well and incubated for 1 hour at room temperature. Plates were washed with PBST five times. Anti-rabbit HRP conjugated was diluted 1 : 3,000 in Buffer C, 30 μL was added to each well and incubated for 1 hour at RT. Plates were washed with PBST five times. Colorimetric HRP substrate (30 μL/well) was added to the plate and developed at RT for 10 minutes. The reaction was quenched with addition of 30 μL/well 10% H2PO4 and the absorbance was measured at wavelength 450 nm.
This data and image were courteously provided by Dr. Garrett Gibbons, University of Pennsylvania.
関連する標識済み抗体及び組成の異なる製品 (5)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Tau Alzheimer's Disease antibody [GT-38] - Conformation-Specific
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific
-
Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific - BSA and Azide free
Reactivity data
製品の詳細
What is this antibody validated in?
Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (ab246808) is a mouse monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), ELISA in Human samples.
Other related products
We have a range of other formats of antibody clone [GT-38] also available for your convenience: ab246808, Carrier free - ab254274, Alexa Fluor® 488 - ab317594, Alexa Fluor® 594 - ab317763, Alexa Fluor® 647 - ab317764, Alexa Fluor® 555 - ab320065
Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Tau protein impacts the dynamics of the neuronal cytoskeleton. Tau is part of the intracellular transport system where it facilitates the movement of organelles and proteins along axons. This function is essential for neuron communication and resilience. Tau interacts with and regulates microtubule-associated complexes ensuring efficient intracellular transport. Its role in cytoskeletal integrity strongly influences cell signaling pathways critical for synaptic plasticity and neuronal survival.
Pathways
Tau protein plays a significant part in cellular transport and signal transduction pathways. One key pathway is the MAPK signaling pathway where tau's phosphorylation state influences neuronal response to external stimuli. Additionally tau is involved in the PI3K/AKT pathway affecting cell growth and survival. Within these pathways tau's phosphorylation is regulated by kinases including GSK-3Β and CDK5 while phosphatases like PP2A dephosphorylate tau to maintain its functional state.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (10)
Recent publications for all applications. Explore the full list and refine your search
Alzheimer's & dementia : the journal of the Alzheimer's Association 20:8758-8768 PubMed39439289
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica communications 12:94 PubMed38867338
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta neuropathologica 146:31-50 PubMed37154939
2023
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology reports 10:87-96 PubMed36691605
2023
Applications
IHC-P
Species
Human
Cell reports 36:109325 PubMed34233183
2021
Applications
Unspecified application
Species
Unspecified reactive species
Alzheimer's & dementia : the journal of the Alzheimer's Association 17:1554-1574 PubMed33797838
2021
Applications
Unspecified application
Species
Unspecified reactive species
Brain : a journal of neurology 143:1572-1587 PubMed32390044
2020
Applications
IHC
Species
Human
Nature communications 11:7 PubMed31911587
2020
Applications
IHC
Species
Human
Acta neuropathologica communications 7:34 PubMed30832741
2019
Applications
IHC-P, IF
Species
Human, Human
Journal of neuropathology and experimental neurology 77:216-228 PubMed29415231
2018
Applications
sELISA, Dot, IHC-P
Species
Human, Human, Human
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com